Syndax Pharmaceuticals, Inc. (SNDX)

Syndax Pharmaceuticals, Inc. (SNDX) is a healthcare company (biotechnology) based in the United States. The share price is $9.20, up 0.77% on the day, which values the company at $828.26M. Price as of 18 Nov 2026, 10:38 UTC, from Yahoo Finance.

Key facts

Share price
$9.20+0.77% today
Market value
$828.26M
Funk Score
27/100
Against its own history
Well below its usual priceusual price $30.39
200-week average
$18.2650% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Syndax Pharmaceuticals, Inc. in more detail

SNDX trades at -11.8× next year's expected earnings, 2.9× sales. Measured against its own history, the price is 70% below what its usual multiples would imply ($30.39) — well below its usual price. It sits 50% below its 200-week average of $18.26.

Over the last five fiscal years Syndax Pharmaceuticals, Inc. has compounded revenue 157.7% a year. Its Funk Score is 27 out of 100 (financial strength 2.8, profitability 0.3, value 5.0, each out of 10).

In its favour: More cash than debt. Worth checking: Altman Z in the distress zone; Beneish M-score flags the accounts.

Syndax Pharmaceuticals, Inc. (SNDX): questions and answers

What is Syndax Pharmaceuticals, Inc.'s market cap?

Syndax Pharmaceuticals, Inc. is valued at $828.26M at a share price of $9.20.

Is SNDX overvalued or undervalued?

Against its own history, SNDX is well below its usual price: the price is 70% below the $30.39 implied by the median multiples it has traded at (price / sales, price / book). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is SNDX above its 200-week moving average?

No. SNDX is 49.6% below its 200-week average of $18.26. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Syndax Pharmaceuticals, Inc. growing?

Over the last five fiscal years Syndax Pharmaceuticals, Inc.'s revenue grew 157.7% a year; over ten years revenue grew 75.4% a year.

Does SNDX pay a dividend?

Syndax Pharmaceuticals, Inc. does not currently pay a regular dividend.

Cite this page

Funkfolio, “Syndax Pharmaceuticals, Inc. (SNDX) stock: price, valuation and fundamentals”, data as of 18 November 2026. https://funkfolio.com/stock/SNDX

Underlying data: Yahoo Finance; company filings with the SEC.